Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.40 +0.06%
Revenue Growth %: +5.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +5.9%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.11, $0.02 better than the analyst estimate of $0.09. Revenue for the quarter came in at $30.2 million versus the consensus estimate of $32.1 million.
For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
